Hi everyone,

As Ali Moore and Henry Edwards' close friends and family, we are raising funds for Ali as she has a long road ahead while undergoing cancer treatments.

If you don't know Ali's story, please keep reading.

We would like to help Ali as much as we can but we can't do it alone. If you have anything to contribute, or if you could please share this story with your network, we can give Ali the best possible chance of getting healthier.

Together, our contributions as a community will determine the treatment options Ali can consider.

********

Ali was diagnosed with early-stage triple negative breast cancer in 2023 at just 28 years old after feeling a lump in her left breast. Triple negative breast cancer is the most aggressive subtype of breast cancer and has historically had the fewest treatment options. Ali had no direct family history or genetic pre-disposition to breast cancer.

Following diagnosis, Ali underwent 6 months of chemotherapy, a double mastectomy, 5 weeks of radiation and 12 months of immunotherapy. Following surgery in March 2024, she was deemed as having a complete response to treatment, meaning the risk of recurrence was only 8%. Ali’s immunotherapy was finalised in October 2024, and she walked out of the treatment centre for what she thought was the last time.

Ali’s original treatment left her with severe side effects, including arthritis which left her virtually bedridden and an inflammatory demyelinating process in her brain (similar to multiple sclerosis). These auto-immune diseases were a reaction to the immunotherapy that Ali received but are fortunately now under control through the ongoing use of steroids.

In December 2024 Ali started experiencing unusual symptoms. A PET scan revealed that the cancer had spread around the body, and Ali was diagnosed with metastatic stage 4 breast cancer. She began chemotherapy again in January 2025 and has been receiving it ever since. Metastatic breast cancer is considered an incurable disease, with patients typically receiving long-term chemotherapy for the rest of their lives. However, Ali and Henry are optimistic they can get through this and are taking a “no stones unturned” approach.

While the costs of seeing the oncologist and chemotherapy are covered by Medicare, they have still been left tens of thousands out of pocket. Supplements are costing hundreds of dollars a week, as well as appointments with medical specialists, acupuncturists, naturopaths etc, as well as a $30,000 surgery. After speaking with several specialists, Ali was referred to an oncologist in Germany, where treatment options are more personalised and have a very high success rate. Ali has already undergone rigorous laboratory testing of her cancer and her German doctors have been able to optimise a combination of supplements and repurposed drugs that will best work with Ali’s chemotherapy to fight her cancer. In addition, there are emerging new personalised ‘vaccine’ therapies in places like Germany and Japan which have had spectacular results for cancer patients in seemingly dire situations. These are personalised vaccines in which doctors essentially train your immune system to fight your specific cancer based on its unique genetic profile.

In the coming months, Ali will continue with her current treatment and begin the genetic testing to explore the viability of vaccine therapy. The testing and production process for the vaccines typically takes between 6 to 9 months with the vaccines administered monthly over the course of 12 to 18 months. The total cost of exploring and receiving this treatment is more than $140,000 – not including the costs of travel or accommodation. Ali and Henry are hopeful this treatment option will cure Ali’s cancer, and she will eventually be able to stop chemotherapy and live a normal, happy, healthy life.